Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in Europe (PIONEER) is a European network of excellence for big data in prostate cancer, consisting of 32 private and public stakeholders from 9 countries across Europe. Launched by the Innovative Medicines Initiative 2 and part of the Big Data for Better Outcomes Programme (BD4BO), the overarching goal of PIONEER is to provide high-quality evidence on prostate cancer management by unlocking the potential of big data. The project has identified critical evidence gaps in prostate cancer care, via a detailed prioritization exercise including all key stakeholders. By standardizing and integrating existing high-quality and multidisciplinary data sources from patients with prostate cancer across different stages of the disease, the resulting big data will be assembled into a single innovative data platform for research. Based on a unique set of methodologies, PIONEER aims to advance the field of prostate cancer care with a particular focus on improving prostate-cancer-related outcomes, health system efficiency by streamlining patient management, and the quality of health and social care delivered to all men with prostate cancer and their families worldwide.

dx.doi.org/10.1038/s41585-020-0324-x, hdl.handle.net/1765/127499
Nature Reviews. Urology
no subscription
Erasmus MC: University Medical Center Rotterdam

Omar, M.I. (Muhammad Imran), Roobol-Bouts, M.J, Ribal, M.J. (Maria J.), Abbott, T. (Thomas), Agapow, P.-M. (Paul-Michael), Araujo, S. (Sonia), … Kermani, N.Z. (Nazanin Zounemat). (2020). Introducing PIONEER: a project to harness big data in prostate cancer research. Nature Reviews. Urology. doi:10.1038/s41585-020-0324-x